Skip to main content
SpringerLink
Log in

Making the biotech IPO work

  • Correspondence
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Capital investment and end valuations for each technology class.

References

  1. Foster, R.N. Innovation: The Attacker's Advantage (Summit Books, New York; 1986).

    Book  Google Scholar 

  2. Christensen, C.M. & Raynor, M.E. The Innovator's Solution: Creating and Sustaining Successful Growth (Harvard Business School Press, Boston; 2003).

    Google Scholar 

  3. McNamee, L.M. & Ledley, F.D. Nat. Biotechnol. 30, 937–943 (2012).

    Article  CAS  Google Scholar 

  4. DiMasi, J.A., Feldman, L., Seckler, A. & Wilson, A. Clin. Pharmacol. Ther. 87, 272–277 (2010).

    Article  CAS  Google Scholar 

  5. Gschwind, A., Fischer, O.M. & Ullrich, A. Nat. Rev. Cancer 4, 361–370 (2004).

    Article  CAS  Google Scholar 

  6. Sheridan, C. Nat. Biotechnol. 29, 121–128 (2011).

    Article  CAS  Google Scholar 

  7. Cockburn, I.H.R. Proc. Natl. Acad. Sci. USA 93, 12725–12730 (1996).

    Article  CAS  Google Scholar 

  8. Pisano, G.P. Science Business: the Promise, the Reality, and the Future of Biotech (Harvard Business School Press, Boston; 2006).

    Google Scholar 

  9. Guedj, I. & Scharfstein, D. Organizational Scope and Investment: Evidence from the Drug Development Strategies of Biopharmaceutical Firms. NBER working paper 10933 (National Bureau of Economic Research, 2004).

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laura McNamee and Fred Ledley are at the Center for Integration of Science and Industry, Bentley University, Waltham, Massachusetts, USA.,

    Laura McNamee & Fred Ledley

Authors
  1. Laura McNamee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fred Ledley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fred Ledley.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McNamee, L., Ledley, F. Making the biotech IPO work. Nat Biotechnol 31, 969–970 (2013). https://doi.org/10.1038/nbt.2711

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2711

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation